Discover research programs and initiatives that seek to inform prevention, diagnosis, and treatment for today’s major health challenges and conditions.
NHLBI-supported research has contributed to heart failure treatments using breakthrough therapies.
BioData Catalyst is a cloud-based ecosystem with data and analytic capabilities to advance research on heart, lung, blood, and sleep diseases, disorders, and conditions.
CEAL is helping communities hardest hit by COVID-19. Learn more about CEAL and its programs.
Sleep deprivation and deficiency are conditions that occur when you don't get enough good quality sleep when your body needs it. This can lead to physical and mental health problems.
Cardiac arrest is a life-threatening condition in which the heart suddenly stops beating.
Bronchiectasis is caused by damage to the airways in the lungs. The damage makes it hard to clear mucus from the airways, which can lead to frequent serious lung infections.
Cigarette smoking causes about 1 in every 5 deaths in the United States each year. Smoking harms nearly every organ in the body and raises your risk of heart and blood vessel diseases.
A stroke happens when blood flow to the brain is blocked. This prevents the brain from getting oxygen and nutrients from the blood.
Respiratory failure is a serious condition that makes it difficult to breathe on your own. Your lungs also can’t get enough oxygen into your blood.
The NHLBI has materials for patients and health professionals on many health topics, such as asthma, heart disease, and sickle cell disease.
The National Heart, Lung, and Blood Institute (NHLBI) provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood disorders and enhance the health of all individuals so that they can live longer and more fulfilling lives.